Reference health
Poly(Lactic Acid) and Poly(Lactic- <i>Co</i> -Glycolic Acid) Particles as Versatile Carrier Platforms for Vaccine Delivery
104/104 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 104 checked references that resolve
resolves10.1016/j.immuni.2007.11.003
How Do Adjuvants Work? Important Considerations for New Generation Adjuvants
resolves10.1002/jps.22284
Vaccines with Aluminum-containing Adjuvants: Optimizing Vaccine Efficacy and Thermal Stability
resolves10.1002/adhm.201200268
Micro and Nanoparticle‐Based Delivery Systems for Vaccine Immunotherapy: An Immunological and Materials Perspective
resolves10.1016/j.drudis.2011.04.006
Particulate vaccines: on the quest for optimal delivery and immune response
resolves10.1016/0142-9612(96)85754-1
Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/ polyglycolic acid copolymers
resolves10.1016/j.jconrel.2013.03.010
Immune system targeting by biodegradable nanoparticles for cancer vaccines
resolves10.1016/j.jconrel.2006.07.006
Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity
resolves10.1016/j.vaccine.2007.08.060
Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits
resolves10.1038/nm.2866
Large intestine–targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection
resolves10.1016/j.ijpharm.2008.04.042
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles
resolves10.1016/S0169-409X(02)00228-4
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
resolves10.1038/nature09737
Programming the magnitude and persistence of antibody responses with innate immunity
resolves10.1016/j.jconrel.2006.02.006
Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models
resolves10.1016/j.jconrel.2013.01.015
Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties
resolves10.1016/0378-5173(89)90281-0
Nanocapsule formation by interfacial polymer deposition following solvent displacement
resolves10.1016/j.ijpharm.2007.05.054
Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation
resolves10.2147/IJN.S18905
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
resolves10.1016/j.jconrel.2012.01.043
PLGA-based nanoparticles: An overview of biomedical applications
resolves10.1016/S0939-6411(00)00079-5
Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination
resolves10.1016/j.ejpb.2009.02.002
Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage
resolves10.1016/S0167-7799(98)01272-4
Single-administration vaccines: controlled-release technology to mimic repeated immunizations
resolves10.1016/j.addr.2004.09.003
Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens
resolves10.1016/S0171-2985(11)80470-5
Controlled-Release Vaccines-Biodegradable Polylactide/Polyglycolide (PL/PG) Microspheres as Antigen Vehicles
resolves10.1002/jbm.10019
Uptake of poly(<scp>D,L</scp>‐lactic‐<i>co</i>‐glycolic acid) microspheres by antigen‐presenting cells <i>in vivo</i>
resolves10.1016/j.biomaterials.2010.04.021
Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells
resolves10.1615/CritRevTherDrugCarrierSyst.v19.i1.20
Recent Advances in the Stabilization of Proteins Encapsulated in Injectable PLGA Delivery Systems
resolves10.1023/A:1011998615267
Improving Stability and Release Kinetics of Microencapsulated Tetanus Toxoid by Co-Encapsulation of Additives
resolves10.1023/A:1007582911958
Visual Evidence of Acidic Environment Within Degrading Poly(lactic-co-glycolic acid) (PLGA) Microspheres
resolves10.1586/erv.11.126
The long-term potential of biodegradable poly(lactideco-glycolide) microparticles as the next-generation vaccine adjuvant
resolves10.1111/j.2042-7158.1993.tb05532.x
Immune Response to Nasal Delivery of Antigenically Intact Tetanus Toxoid Associated with Poly(<scp>l</scp>-lactic acid) Microspheres in Rats, Rabbits and Guinea-pigs
resolves10.1016/S0168-3659(98)00173-4
Adsorption of serum albumin to thin films of poly(lactide-co-glycolide)
resolves10.1023/A:1011950732105
Enhanced Immunogenicity of Microencapsulated Tetanus Toxoid with Stabilizing Agents
resolves10.1023/A:1007513425337
Stabilization of Proteins Encapsulated in Cylindrical Poly(lactide-co-glycolide) Implants: Mechanism of Stabilization by Basic Additives
resolves10.1038/71916
Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)
resolves10.1023/A:1011009117586
Stabilization and Controlled Release of Bovine Serum Albumin Encapsulated in Poly(D, L-lactide) and Poly(ethylene glycol) Microsphere Blends
resolves10.1016/S0168-3659(00)00226-1
Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1
resolves10.2174/156720106775197565
Polylactide-Co-Glycolide Microparticles with Surface Adsorbed Antigens as Vaccine Delivery Systems
resolves10.1007/s11095-004-7666-6
Adsorption of a Novel Recombinant Glycoprotein from HIV (Env gp120dV2 SF162) to Anionic PLG Microparticles Retains the Structural Integrity of the Protein, Whereas Encapsulation in PLG Microparticles Does Not
resolves10.1016/j.vaccine.2010.06.121
Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: Nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen
resolves10.1016/S0378-5173(02)00342-3
Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants
resolves10.3109/10837450903479962
Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and<i>Quillaja</i>saponins after nasal immunization in rabbit
resolves10.1016/S0264-410X(99)00191-7
Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs
resolves10.3109/10611860903386920
Humoral and cell-mediated immune-responses after administration of a single-shot recombinant hepatitis B surface antigen vaccine formulated with cationic poly(l-lactide) microspheres
resolves10.1021/mp100255c
Aerosolized PLA and PLGA Nanoparticles Enhance Humoral, Mucosal and Cytokine Responses to Hepatitis B Vaccine
resolves10.2174/156720109788680886
Evaluation of a Diphtheria and Tetanus PLGA Microencapsulated Vaccine Formulation without Stabilizers
resolves10.1016/S0264-410X(99)00313-8
Improved immunogenicity of a core-coated tetanus toxoid delivery system
resolves10.1080/10611860701637982
M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B
resolves10.1016/j.biomaterials.2012.03.041
Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype
resolves10.1155/2011/181646
An Overview on the Field of Micro- and Nanotechnologies for Synthetic Peptide-Based Vaccines
resolves10.1111/j.1600-065X.2010.00978.x
Use of defined TLR ligands as adjuvants within human vaccines
resolves10.1128/CVI.00703-12
Blueprints of Signaling Interactions between Pattern Recognition Receptors: Implications for the Design of Vaccine Adjuvants
resolves10.1038/ni1223
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells
resolves10.1016/j.intimp.2009.01.027
Regulatory T cells and Toll-like receptors: What is the missing link?
resolves10.1111/j.1365-2249.2010.04091.x
Modulation of immune responses through direct activation of Toll-like receptors to T cells
resolves10.1182/blood-2005-10-4015
Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo
resolves10.1002/eji.200737169
Antigen co‐encapsulated with adjuvants efficiently drive protective T cell immunity
resolves10.1016/j.jconrel.2012.06.034
Potential of NOD receptor ligands as immunomodulators in particulate vaccine carriers
resolves10.4049/jimmunol.1000768
TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis
resolves10.1016/j.jconrel.2004.09.014
Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery
resolves10.4110/in.2013.13.1.30
Induction of Potent Antigen-specific Cytotoxic T Cell Response by PLGA-nanoparticles Containing Antigen and TLR Agonist
resolves10.1016/j.jconrel.2005.10.010
Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency
resolves10.1073/pnas.1313152110
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose
resolves10.1016/j.vaccine.2014.02.027
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
resolves10.4110/in.2011.11.3.163
Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the Antigen
resolves10.1016/j.ejps.2011.11.022
Soybean agglutinin coated PLA particles entrapping candidate vaccines induces enhanced primary and sustained secondary antibody response from single point immunization
resolves10.4049/jimmunol.172.5.2845
Mannose Receptor Targeting of Tumor Antigen pmel17 to Human Dendritic Cells Directs Anti-Melanoma T Cell Responses via Multiple HLA Molecules
resolves10.4049/jimmunol.178.10.6259
Antigenic Targeting of the Human Mannose Receptor Induces Tumor Immunity
resolves10.1016/j.jconrel.2013.12.011
A platform to screen for C-type lectin receptor-binding carbohydrates and their potential for cell-specific targeting and immune modulation
resolves10.1016/j.addr.2013.05.007
Targeting C-type lectin receptors with multivalent carbohydrate ligands
resolves10.1016/j.biomaterials.2011.04.082
The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells
resolves10.1007/s11095-011-0459-9
Activation of Antigen-Specific T Cell-Responses by Mannan-Decorated PLGA Nanoparticles
resolves10.1016/j.ejps.2008.11.013
Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages
resolves10.3109/10611861003733946
Lectin anchored PLGA nanoparticles for oral mucosal immunization against hepatitis B
resolves10.1007/BF00318877
Selective binding and transcytosis of Ulex europaeus 1 lectin by mouse Peyer's patch M-cells in vivo
resolves10.1006/bbrc.2000.4038
Expression of Specific Markers and Particle Transport in a New Human Intestinal M-Cell Model
resolves10.1124/jpet.106.107847
Identification of Cell Adhesion Molecules in the Human Follicle-Associated Epithelium That Improve Nanoparticle Uptake into the Peyer’s Patches
resolves10.1016/j.jconrel.2007.04.021
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
resolves10.1016/j.biomaterials.2013.11.073
Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan
resolves10.1016/j.ejpb.2013.06.017
Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: Effect of mucoadhesive coating on antigen uptake and immune adjuvant activity
resolves10.1016/S0264-410X(02)00521-2
Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro
resolves10.1016/j.biomaterials.2007.08.015
Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response
The 2 references without a DOI — listed, not checked
no DOI — not checkedXu FH , ZhangQ. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres. Yao Xue Xue Bao42 (1), 1–7 (2007).
no DOI — not checkedHu L ZY , GaoC. Influence of structures and properties of polymer nanoparticles on their cellular uptake and cell functions. Prog. Chem.21, 1254–1267 (2009).
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2217/nnm.14.156"><img src="https://citestamp.com/citestamped/10.2217/nnm.14.156/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2217/nnm.14.156)